Krish Biotech Research Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 17-07-2024
- Paid Up Capital ₹ 2.58 M
as on 17-07-2024
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.90 M
as on 17-07-2024
- Satisfied Charges ₹ 0.50 M
as on 17-07-2024
- Revenue -10.56%
(FY 2023)
- Profit -221.15%
(FY 2023)
- Ebitda -62.04%
(FY 2023)
- Net Worth -26.61%
(FY 2023)
- Total Assets -5.46%
(FY 2023)
About Krish Biotech Research
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.58 M.
The company currently has active open charges totaling ₹0.90 M. The company has closed loans amounting to ₹0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Lakhpat Agarwal, Sangita Churiwal, Om Sonthalia, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999WB2007PTC116917
- Company No.
116917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Krish Biotech Research Private Limited offer?
Krish Biotech Research Private Limited offers a wide range of products and services, including Turnkey Consultants & Solutions, Engineering Project.
Who are the key members and board of directors at Krish Biotech Research?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakhpat Agarwal  | Director | 11-Jun-2019 | Current |
| Sangita Churiwal | Director | 10-May-2010 | Current |
| Om Sonthalia | Director | 20-Mar-2017 | Current |
| Ankita Agarwal | Director | 11-Jun-2019 | Current |
Financial Performance and Corporate Structure Insights of Krish Biotech Research.
Krish Biotech Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.56% decrease. The company also saw a substantial fall in profitability, with a 221.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krish Biotech Research?
In 2023, Krish Biotech Research had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Truly Pest Solution Private LimitedActive 15 years 6 monthsSangita Churiwal and Ankita Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Jun 2022 | ₹0.50 M | Open |
Hdfc Bank Limited Creation Date: 15 Jan 2021 | ₹0.40 M | Open |
Hdfc Bank Limited Creation Date: 19 May 2015 | ₹0.50 M | Satisfied |
How Many Employees Work at Krish Biotech Research?
Krish Biotech Research has a workforce of 86 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krish Biotech Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krish Biotech Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
